Prevention of metastasis by a polyamine synthesis inhibitor in an animal bone metastasis model

Oncology

Volumn 59, Issue 1, 2000, Pages 75-80

  Wakabayashi, Hiroki ^a,b   Hibasami, Hiroshige ^a   Iida, Kohji ^a   Satoh, Norifumi ^a   Yamazaki, Takashi ^a   Sonoda, Jun ^a   Hirata, Hitoshi ^a   Nakashima, Kunio ^a   Uchida, Atsumasa ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Animal model; Antitumor effect; Bone metastasis; Polyamine synthesis inhibitor

Indexed keywords

HYDRAZONE DERIVATIVE; METHYLGLYOXAL BIS(CYCLOPENTYLAMINIDOHYDRAZONE); POLYAMINE SYNTHESIS INHIBITOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE METASTASIS; CONTROLLED STUDY; DRUG EFFECT; DRUG USE; MOUSE; NONHUMAN; POLYAMINE SYNTHESIS; PRIORITY JOURNAL;

EID: 0033937204     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012141     Document Type: Article

References (19)

1. Woodhouse EC, Chuaqui RF, Liotta LA: General mechanisms of metastasis. Cancer 1997; 80:1529-1538.
2. Mundy GR: Mechanisms of bone metastasis. Cancer 1997;80:1546-1556.
3. Nakai M, Mundy GR, Williams PJ, Boyce B, Yoneda T: Asynthetic antagonist to laminin inhibits the formation of osteolytic metastases by human melanoma cells in nude mice. Cancer Res 1992;52:5395-5399.
4. Sasaki A, Boyce BF, Story B, Wright KR, Chapman M, Boyce R, Mundy GR, Yoneda T: Bisphosphonate risedoronate reduces metastatic human breast cancer burden in bone in nude mice. Cancer Res 1995;55:3551-3557.
5. Mbalaviele G, Dunstan CR, Sasaki A, Williams PJ, Mundy GR, Yoneda T: E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model. Cancer Res 1996;56:4063-4070.
6. Sasaki A, Alcalde RE, Nishiyama A, Lim DD, Mese H, Akedo H, Matsumura T: Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption. Cancer Res 1998;58:462-467.
7. Arugello F, Baggs RB, Frantz CN: A murine model of experimental metastasis to bone and bone marrow. Cancer Res 1998;48:6876-6881.
8. Hibasami H, Maekawa S, Murata T, Nakashima K: Antitumor effect of a new multienzyme inhibitor of polyamine synthetic pathway, methylglyoxal-bis-(cyclopentylamidinohydrazone), against human and mouse leukemia cells. Cancer Res 1989;49:2065-2068.
9. Takigawa M, Enomoto M, Nishida Y, Pan HO, Kinoshita A, Suzuki F: Tumor angiogenesis and polyamines: Alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits B16 melanoma-induced angiogenesis in ovo and the proliferation of vascular endothelial cells in vitro. Cancer Res 1990;50:4131-4138.
10. Sonoda J, Hibasami H, Yamada H, Fujinami S, Nakashima K, Ogihara Y: Methylglyoxalbis(cyclopentylamidinohydrazone) (MGBCP): Antitumor effect against human osteosarcoma cells and combined effect with methotrexate, Adriamycin and 4 hydroperoxyifosfamide. Anticancer Res 1995;15:907-910.
11. Mori K, Hibasami H, Sonoda J, Fijinami S, Sckiguti S, Tajima M, Yamazaki T, Higuchi S, Uchida A, Nakashima K: Effects of methylglyoxal - bis(cyclopentylamidinohydrazone) (MGBCP) on cell cycle progression in three human osteosarcoma cell lines. Anticancer Res 1996;16:2565-2568.
12. Mori K, Hibasami H, Satoh N, Sonoda J, Yamazaki T, Tajima M, Higuchi S, Wakabayashi H, Uchida A, Nakashima K: Induction of apoptotic cell death in three human oesteosarcoma cell lines by a polyamine synthesis inhibitor, methylglyoxal-bis(cyclopentylamidinohydrazone)(MGBCP). Anticancer Res 1997;17: 2385-2390.
13. Maniatis T, Fritsch EF, Sambrook J: Preparation of Genomic DNA. Molecular Cloning, Cold Spring Habor, Cold Spring Harbor Laboratory, 1989, pp 9-14.
14. Russell DR: Clinical relevance of polyamines as biological markers of tumor kinetics. A review. Clin Chem 1977;23:22-25.
15. Sjoerdsma A, Schechter PJ: Chemotherapeutic implications of polyaminc biosynthesis inhibition (review). Clin Pharmacol Ther 1984;35: 287-300.
16. Porter CW, Sufrin JR: Interference with polyamine biosynthesis and/or function by analogs of polyamines or methionine as a potential anticancer chemotherapeutic strategy. Anticancer Res 1986;6:525-542.
17. Block NL, Camuzzi F, Denefrio J, Troner M, Clafin A, Stover G, Politano VA: Chemotherapy of the transplantable adenocarcinoma (R-3327) of the Copenhagen rat. Oncology 1977; 34:110-113.
18. Folkman J: What is the evidence that tumors and angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
19. Jasnis MA, Klein S, Monte M, Davel L, Lustig ES, Algranati ID: Polyamines prevent DGMO-mediatcd inhibition of angiogenesis. Cancer Lett 1994;79:39-43.